Santi Yarlagadda, MD

Make an Appointment
Santi Yarlagadda
Santi Yarlagadda, MD, is a cardiologist at National Jewish Health. Dr. Yarlagadda is in the Division of Cardiology and Department of Medicine.
Assistant Professor
Division of Cardiology
Department of Medicine
5280 Top Doctors 2019 (1st year)

image descriptionPrograms & Services
News & Videos

Education

Education
Albany Medical College, Albany, NY, MD
The University of Texas at Austin, Austin, TX, BS, Major in Biology, Concentration in Cell & Molecular Biology
Residency
Rush University Medical Center, Chicago, IL, Internal Medicine
Fellowship
The University of California, San Francisco, San Francisco, CA, Advanced Heart Failure and Cardiac Transplant Fellowship
The University of Texas Health Science Center at Houston, Memorial Hermann Hospital, M.D. Anderson Cancer Center, LBJ Hospital of Harris County, Houston, TX, Cardiovascular Disease

Board Certification

2019: Advanced Heart Failure and Transplant Cardiology
2017: American Board of Internal Medicine - Cardiovascular Disease
2017: Level II Training in Echocardiography
2017: Level II Training in Invasive Cardiology
2013: American Board of Internal Medicine

Professional Memberships

International Society for Heart and Lung Transplant (ISHLT)
American College of Cardiology (ACC)
American Heart Association (AHA)

Publications

Higgins JP, Yang B, Herrin NE, Yarlagadda S, et al. “Consumption of Energy Beverage is Associated with Attenuation of Arterial Endothelial Flow-Mediated Dilatation.” World Journal of Cardiology. 2017; 9(2):162-166.
 
Shih MJ, Kakodkar SA, Kaid Y, Hassel JL, Yarlagadda S, Fogg LF, Madias C, Krishnan K, Torhman RG. “Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing.” Pacing and Clinical Electrophysiology. 2016; 39: 483–489.
 
Shih M, Kakodkar S, Kaid Y, Hassel J, Yarlagadda S, Fogg L, Madias C, Krishnan K, Trohman R. “Reassessing Risk Factors for High Defibrillation Threshold: The EF-SAGA Risk Score and Implications for Device Testing.” American Heart Association Scientific Sessions, November 10, 2015, Orlando, FL
 
Higgins JP, Yarlagadda S, Yang B. “Cardiovascular Complications of Energy Drinks.” Beverages. 2015; 1(2): 104-126.
 
Gallichio M, Yarlagadda S., Rainow A, Conti D. “Dialysis Time is a Risk Factor for Long-Term Deceased-Donor Transplant Survival.” Transplantation, supplement 2S, 86:41, 2008

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 877.225.5654

 

Locations

  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.